{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,14]],"date-time":"2026-05-14T13:12:16Z","timestamp":1778764336376,"version":"3.51.4"},"reference-count":60,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100012166","name":"National Key Research and Development Program of China","doi-asserted-by":"publisher","award":["2017YFA0505200"],"award-info":[{"award-number":["2017YFA0505200"]}],"id":[{"id":"10.13039\/501100012166","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81570118"],"award-info":[{"award-number":["81570118"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81700475"],"award-info":[{"award-number":["81700475"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81570112"],"award-info":[{"award-number":["81570112"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81700157"],"award-info":[{"award-number":["81700157"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81272886"],"award-info":[{"award-number":["81272886"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003399","name":"Science and Technology Commission of Shanghai Municipality","doi-asserted-by":"publisher","award":["20ZR1430600"],"award-info":[{"award-number":["20ZR1430600"]}],"id":[{"id":"10.13039\/501100003399","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003399","name":"Science and Technology Commission of Shanghai Municipality","doi-asserted-by":"publisher","award":["19ZR1428700"],"award-info":[{"award-number":["19ZR1428700"]}],"id":[{"id":"10.13039\/501100003399","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cellular Signalling"],"published-print":{"date-parts":[[2023,10]]},"DOI":"10.1016\/j.cellsig.2023.110837","type":"journal-article","created":{"date-parts":[[2023,8,4]],"date-time":"2023-08-04T22:04:59Z","timestamp":1691186699000},"page":"110837","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"C","title":["Anlotinib exerts an anti-T-cell acute lymphoblastic leukemia effect in vitro and in vivo"],"prefix":"10.1016","volume":"110","author":[{"given":"Xingming","family":"Zhang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lou","family":"Geng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Li","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yingying","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhihui","family":"Zou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Youping","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hanzhang","family":"Xu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hu","family":"Lei","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yang","family":"Cao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yingli","family":"Wu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wenli","family":"Gu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Li","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.cellsig.2023.110837_bb0005","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1182\/blood.V75.1.174.174","article-title":"Heterogeneity of presenting features and their relation to treatment outcome in 120 children with T-cell acute lymphoblastic leukemia","volume":"75","author":"Pui","year":"1990","journal-title":"Blood"},{"issue":"8","key":"10.1016\/j.cellsig.2023.110837_bb0010","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1038\/nrc.2016.63","article-title":"The genetics and mechanisms of T cell acute lymphoblastic leukaemia","volume":"16","author":"Belver","year":"2016","journal-title":"Nat. Rev. Cancer"},{"issue":"5","key":"10.1016\/j.cellsig.2023.110837_bb0015","doi-asserted-by":"crossref","first-page":"1053","DOI":"10.1182\/blood-2008-10-186536","article-title":"High-resolution genomic profiling of childhood T-ALL reveals frequent copy-number alterations affecting the TGF-beta and PI3K-AKT pathways and deletions at 6q15-16.1 as a genomic marker for unfavorable early treatment response","volume":"114","author":"Remke","year":"2009","journal-title":"Blood"},{"issue":"2","key":"10.1016\/j.cellsig.2023.110837_bb0020","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1073\/pnas.1717125115","article-title":"Identification of fusion genes and characterization of transcriptome features in T-cell acute lymphoblastic leukemia","volume":"115","author":"Chen","year":"2018","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"2","key":"10.1016\/j.cellsig.2023.110837_bb0025","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1002\/path.2789","article-title":"Notch signalling in T-cell lymphoblastic leukaemia\/lymphoma and other haematological malignancies","volume":"223","author":"Aster","year":"2011","journal-title":"J. Pathol."},{"issue":"8","key":"10.1016\/j.cellsig.2023.110837_bb0030","doi-asserted-by":"crossref","first-page":"1689","DOI":"10.1182\/blood-2008-03-147967","article-title":"Notch signaling mediates G1\/S cell-cycle progression in T cells via cyclin D3 and its dependent kinases","volume":"113","author":"Joshi","year":"2009","journal-title":"Blood"},{"issue":"48","key":"10.1016\/j.cellsig.2023.110837_bb0035","doi-asserted-by":"crossref","first-page":"18261","DOI":"10.1073\/pnas.0606108103","article-title":"NOTCH1 directly regulates c-MYC and activates a feed-forward-loop transcriptional network promoting leukemic cell growth","volume":"103","author":"Palomero","year":"2006","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"10","key":"10.1016\/j.cellsig.2023.110837_bb0040","doi-asserted-by":"crossref","first-page":"1203","DOI":"10.1038\/nm1636","article-title":"Mutational loss of PTEN induces resistance to NOTCH1 inhibition in T-cell leukemia","volume":"13","author":"Palomero","year":"2007","journal-title":"Nat. Med."},{"key":"10.1016\/j.cellsig.2023.110837_bb0045","first-page":"943","article-title":"Gamma secretase inhibitors of Notch signaling","volume":"6","author":"Olsauskas-Kuprys","year":"2013","journal-title":"OncoTargets Ther."},{"issue":"3","key":"10.1016\/j.cellsig.2023.110837_bb0050","doi-asserted-by":"crossref","first-page":"909","DOI":"10.3892\/ijo.2014.2525","article-title":"Therapeutic potential of targeting mTOR in T-cell acute lymphoblastic leukemia (review)","volume":"45","author":"Evangelisti","year":"2014","journal-title":"Int. J. Oncol."},{"issue":"25","key":"10.1016\/j.cellsig.2023.110837_bb0055","doi-asserted-by":"crossref","first-page":"3738","DOI":"10.1182\/blood-2014-05-574566","article-title":"ABT-199 mediated inhibition of BCL-2 as a novel therapeutic strategy in T-cell acute lymphoblastic leukemia","volume":"124","author":"Peirs","year":"2014","journal-title":"Blood"},{"issue":"12","key":"10.1016\/j.cellsig.2023.110837_bb0060","article-title":"Two specific drugs, BMS-345541 and purvalanol A induce apoptosis of HTLV-1 infected cells through inhibition of the NF-kappaB and cell cycle pathways","volume":"5","author":"Agbottah","year":"2008","journal-title":"AIDS Res. Ther."},{"issue":"9","key":"10.1016\/j.cellsig.2023.110837_bb0065","doi-asserted-by":"crossref","first-page":"4477","DOI":"10.1182\/blood-2007-09-112920","article-title":"Risk-adjusted therapy of acute lymphoblastic leukemia can decrease treatment burden and improve survival: treatment results of 2169 unselected pediatric and adolescent patients enrolled in the trial ALL-BFM 95","volume":"111","author":"M\u00f6ricke","year":"2008","journal-title":"Blood"},{"issue":"1","key":"10.1016\/j.cellsig.2023.110837_bb0070","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1002\/cncr.27617","article-title":"Dose intensification of daunorubicin and cytarabine during treatment of adult acute lymphoblastic leukemia: results of cancer and leukemia group B study 19802","volume":"119","author":"Stock","year":"2013","journal-title":"Cancer"},{"issue":"3","key":"10.1016\/j.cellsig.2023.110837_bb0075","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1111\/bjh.13142","article-title":"Persistent MRD before and after allogeneic BMT predicts relapse in children with acute lymphoblastic leukaemia","volume":"168","author":"Sutton","year":"2015","journal-title":"Br. J. Haematol."},{"issue":"1","key":"10.1016\/j.cellsig.2023.110837_bb0080","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1182\/hematology.2019000017","article-title":"Moving immunotherapy into the front line in ALL","volume":"2019","author":"Winters","year":"2019","journal-title":"Hematol. Am. Soc. Hematol. Educ. Program"},{"issue":"1","key":"10.1016\/j.cellsig.2023.110837_bb0085","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1186\/s13045-018-0664-7","article-title":"Anlotinib: a novel multi-targeting tyrosine kinase inhibitor in clinical development","volume":"11","author":"Shen","year":"2018","journal-title":"J. Hematol. Oncol."},{"issue":"1","key":"10.1016\/j.cellsig.2023.110837_bb0090","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1186\/s13045-016-0332-8","article-title":"Safety, pharmacokinetics, and antitumor properties of anlotinib, an oral multi-target tyrosine kinase inhibitor, in patients with advanced refractory solid tumors","volume":"9","author":"Sun","year":"2016","journal-title":"J. Hematol. Oncol."},{"issue":"5","key":"10.1016\/j.cellsig.2023.110837_bb0095","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1038\/bjc.2017.478","article-title":"Anlotinib as a third-line therapy in patients with refractory advanced non-small-cell lung cancer: a multicentre, randomised phase II trial (ALTER0302)","volume":"118","author":"Han","year":"2018","journal-title":"Br. J. Cancer"},{"issue":"13","key":"10.1016\/j.cellsig.2023.110837_bb0100","doi-asserted-by":"crossref","first-page":"3567","DOI":"10.1158\/1078-0432.CCR-20-2950","article-title":"Anlotinib in locally advanced or metastatic medullary thyroid carcinoma: a randomized, double-blind phase IIB trial","volume":"27","author":"Li","year":"2021","journal-title":"Clin. Cancer Res."},{"issue":"8","key":"10.1016\/j.cellsig.2023.110837_bb0105","doi-asserted-by":"crossref","first-page":"e702","DOI":"10.1634\/theoncologist.2018-0839","article-title":"Anlotinib versus sunitinib as first-line treatment for metastatic renal cell carcinoma: a randomized phase II clinical trial","volume":"24","author":"Zhou","year":"2019","journal-title":"Oncologist"},{"issue":"10","key":"10.1016\/j.cellsig.2023.110837_bb0110","doi-asserted-by":"crossref","first-page":"e1693","DOI":"10.1002\/onco.13857","article-title":"Anlotinib monotherapy for refractory metastatic colorectal cancer: a double-blinded, placebo-controlled, randomized phase III trial (ALTER0703)","volume":"26","author":"Chi","year":"2021","journal-title":"Oncologist"},{"issue":"5","key":"10.1016\/j.cellsig.2023.110837_bb0115","doi-asserted-by":"crossref","first-page":"1681","DOI":"10.1002\/cam4.3771","article-title":"Anlotinib for previously treated advanced or metastatic esophageal squamous cell carcinoma: a double-blind randomized phase 2 trial","volume":"10","author":"Huang","year":"2021","journal-title":"Cancer Med."},{"issue":"21","key":"10.1016\/j.cellsig.2023.110837_bb0120","doi-asserted-by":"crossref","first-page":"5233","DOI":"10.1158\/1078-0432.CCR-17-3766","article-title":"Safety and efficacy of anlotinib, a multikinase angiogenesis inhibitor, in patients with refractory metastatic soft-tissue sarcoma","volume":"24","author":"Chi","year":"2018","journal-title":"Clin. Cancer Res."},{"issue":"4","key":"10.1016\/j.cellsig.2023.110837_bb0125","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1038\/s41419-021-03685-w","article-title":"Directly targeting c-Myc contributes to the anti-multiple myeloma effect of anlotinib","volume":"12","author":"Cao","year":"2021","journal-title":"Cell Death Dis."},{"issue":"5","key":"10.1016\/j.cellsig.2023.110837_bb0130","doi-asserted-by":"crossref","first-page":"1261","DOI":"10.1038\/s41375-022-01516-1","article-title":"Targeting the NOTCH1-MYC-CD44 axis in leukemia-initiating cells in T-ALL","volume":"36","author":"Piya","year":"2022","journal-title":"Leukemia"},{"key":"10.1016\/j.cellsig.2023.110837_bb0135","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1016\/j.canlet.2019.10.015","article-title":"Targeting USP9x\/SOX2 axis contributes to the anti-osteosarcoma effect of neogambogic acid","volume":"469","author":"Chen","year":"2020","journal-title":"Cancer Lett."},{"issue":"20","key":"10.1016\/j.cellsig.2023.110837_bb0140","doi-asserted-by":"crossref","first-page":"2191","DOI":"10.1001\/jama.2013.281053","article-title":"World medical association declaration of Helsinki: ethical principles for medical research involving human subjects","volume":"310","author":"Association WM","year":"2013","journal-title":"JAMA"},{"key":"10.1016\/j.cellsig.2023.110837_bb0145","doi-asserted-by":"crossref","first-page":"A3.B.1","DOI":"10.1002\/0471142735.ima03bs111","article-title":"Trypan blue exclusion test of cell viability","volume":"111","author":"Strober","year":"2015","journal-title":"Curr. Protoc. Immunol."},{"key":"10.1016\/j.cellsig.2023.110837_bb0150","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/j.canlet.2016.12.010","article-title":"Rocaglamide breaks TRAIL-resistance in human multiple myeloma and acute T-cell leukemia in vivo in a mouse xenogtraft model","volume":"389","author":"Wu","year":"2017","journal-title":"Cancer Lett."},{"issue":"5","key":"10.1016\/j.cellsig.2023.110837_bb0155","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1038\/s41389-021-00331-0","article-title":"A novel dual HDAC and HSP90 inhibitor, MPT0G449, downregulates oncogenic pathways in human acute leukemia in vitro and in vivo","volume":"10","author":"Wu","year":"2021","journal-title":"Oncogenesis"},{"issue":"1","key":"10.1016\/j.cellsig.2023.110837_bb0160","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/S0145-2126(98)00133-7","article-title":"Heterogeneity of T-acute lymphoblastic leukemia (T-ALL) cell lines: suggestion for classification by immunophenotype and T-cell receptor studies","volume":"23","author":"Burger","year":"1999","journal-title":"Leuk. Res."},{"issue":"9","key":"10.1016\/j.cellsig.2023.110837_bb0165","doi-asserted-by":"crossref","first-page":"766","DOI":"10.1038\/s41419-020-02938-4","article-title":"Reactive oxygen species mediate anlotinib-induced apoptosis via activation of endoplasmic reticulum stress in pancreatic cancer","volume":"11","author":"Yang","year":"2020","journal-title":"Cell Death Dis."},{"issue":"4","key":"10.1016\/j.cellsig.2023.110837_bb0170","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1038\/s41419-019-1492-6","article-title":"\u03b2-Thujaplicin induces autophagic cell death, apoptosis, and cell cycle arrest through ROS-mediated Akt and p38\/ERK MAPK signaling in human hepatocellular carcinoma","volume":"10","author":"Zhang","year":"2019","journal-title":"Cell Death Dis."},{"issue":"5694","key":"10.1016\/j.cellsig.2023.110837_bb0175","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1126\/science.1102160","article-title":"Activating mutations of NOTCH1 in human T cell acute lymphoblastic leukemia","volume":"306","author":"Weng","year":"2004","journal-title":"Science"},{"key":"10.1016\/j.cellsig.2023.110837_bb0180","first-page":"11","article-title":"The catalogue of somatic mutations in cancer (COSMIC)","author":"Forbes","year":"2008","journal-title":"Curr. Protoc. Hum. Genet."},{"issue":"D945\u2013950","key":"10.1016\/j.cellsig.2023.110837_bb0185","doi-asserted-by":"crossref","first-page":"D945","DOI":"10.1093\/nar\/gkq929","article-title":"COSMIC: mining complete cancer genomes in the catalogue of somatic mutations in cancer","volume":"39","author":"Forbes","year":"2011","journal-title":"Nucleic Acids Res."},{"issue":"1","key":"10.1016\/j.cellsig.2023.110837_bb0190","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1128\/MCB.24.1.144-153.2004","article-title":"A network of immediate early gene products propagates subtle differences in mitogen-activated protein kinase signal amplitude and duration","volume":"24","author":"Murphy","year":"2004","journal-title":"Mol. Cell. Biol."},{"issue":"15","key":"10.1016\/j.cellsig.2023.110837_bb0195","doi-asserted-by":"crossref","first-page":"5565","DOI":"10.1128\/MCB.02372-06","article-title":"Integrin-linked kinase controls Notch1 signaling by down-regulation of protein stability through Fbw7 ubiquitin ligase","volume":"27","author":"Mo","year":"2007","journal-title":"Mol. Cell. Biol."},{"issue":"14","key":"10.1016\/j.cellsig.2023.110837_bb0200","doi-asserted-by":"crossref","first-page":"3834","DOI":"10.1158\/1078-0432.CCR-16-2880","article-title":"Stabilization of Notch1 by the Hsp90 chaperone is crucial for T-cell leukemogenesis","volume":"23","author":"Wang","year":"2017","journal-title":"Clin. Cancer Res."},{"issue":"10","key":"10.1016\/j.cellsig.2023.110837_bb0205","doi-asserted-by":"crossref","first-page":"8033","DOI":"10.1074\/jbc.M108552200","article-title":"c-Cbl binding and ubiquitin-dependent lysosomal degradation of membrane-associated Notch1","volume":"277","author":"Jehn","year":"2002","journal-title":"J. Biol. Chem."},{"issue":"9","key":"10.1016\/j.cellsig.2023.110837_bb0210","doi-asserted-by":"crossref","first-page":"1133","DOI":"10.4161\/cc.3.9.1145","article-title":"The life cycle of C-myc: from synthesis to degradation","volume":"3","author":"Sears","year":"2004","journal-title":"Cell Cycle"},{"issue":"9","key":"10.1016\/j.cellsig.2023.110837_bb0215","doi-asserted-by":"crossref","first-page":"1124","DOI":"10.1182\/blood-2016-09-692582","article-title":"The NOTCH1-MYC highway toward T-cell acute lymphoblastic leukemia","volume":"129","author":"Sanchez-Martin","year":"2017","journal-title":"Blood"},{"issue":"7291","key":"10.1016\/j.cellsig.2023.110837_bb0220","doi-asserted-by":"crossref","first-page":"1052","DOI":"10.1038\/nature08878","article-title":"Therapeutic antibody targeting of individual Notch receptors","volume":"464","author":"Wu","year":"2010","journal-title":"Nature"},{"issue":"7","key":"10.1016\/j.cellsig.2023.110837_bb0225","doi-asserted-by":"crossref","first-page":"1279","DOI":"10.1038\/sj.leu.2404258","article-title":"CUTLL1, a novel human T-cell lymphoma cell line with t(7;9) rearrangement, aberrant NOTCH1 activation and high sensitivity to gamma-secretase inhibitors","volume":"20","author":"Palomero","year":"2006","journal-title":"Leukemia"},{"issue":"1","key":"10.1016\/j.cellsig.2023.110837_bb0230","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1186\/s13046-019-1458-7","article-title":"Notch1 signaling in NOTCH1-mutated mantle cell lymphoma depends on Delta-like ligand 4 and is a potential target for specific antibody therapy","volume":"38","author":"Silkenstedt","year":"2019","journal-title":"J. Exp. Clin. Cancer Res."},{"issue":"2","key":"10.1016\/j.cellsig.2023.110837_bb0235","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1182\/blood-2005-06-2553","article-title":"Activating Notch1 mutations in mouse models of T-ALL","volume":"107","author":"O\u2019Neil","year":"2006","journal-title":"Blood"},{"issue":"6","key":"10.1016\/j.cellsig.2023.110837_bb0240","doi-asserted-by":"crossref","first-page":"1618","DOI":"10.1158\/1535-7163.MCT-10-0034","article-title":"Evaluation of selective gamma-secretase inhibitor PF-03084014 for its antitumor efficacy and gastrointestinal safety to guide optimal clinical trial design","volume":"9","author":"Wei","year":"2010","journal-title":"Mol. Cancer Ther."},{"issue":"19","key":"10.1016\/j.cellsig.2023.110837_bb0245","doi-asserted-by":"crossref","first-page":"2348","DOI":"10.1200\/JCO.2011.36.8282","article-title":"Phase I study of RO4929097, a gamma secretase inhibitor of Notch signaling, in patients with refractory metastatic or locally advanced solid tumors","volume":"30","author":"Tolcher","year":"2012","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.cellsig.2023.110837_bb0250","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1038\/s41392-018-0028-3","article-title":"USP7 deubiquitinates and stabilizes NOTCH1 in T-cell acute lymphoblastic leukemia","volume":"3","author":"Shan","year":"2018","journal-title":"Signal Transduct. Target. Ther."},{"issue":"8","key":"10.1016\/j.cellsig.2023.110837_bb0255","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1038\/s41419-020-02904-0","article-title":"Transcriptome profiling analysis reveals that ATP6V0E2 is involved in the lysosomal activation by anlotinib","volume":"11","author":"Sun","year":"2020","journal-title":"Cell Death Dis."},{"issue":"7","key":"10.1016\/j.cellsig.2023.110837_bb0260","doi-asserted-by":"crossref","first-page":"1552","DOI":"10.1016\/j.cell.2013.05.041","article-title":"The ubiquitin ligase FBXW7 modulates leukemia-initiating cell activity by regulating MYC stability","volume":"153","author":"King","year":"2013","journal-title":"Cell"},{"issue":"2","key":"10.1016\/j.cellsig.2023.110837_bb0265","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1182\/blood-2006-01-0172","article-title":"MYC levels govern hematopoietic tumor type and latency in transgenic mice","volume":"108","author":"Smith","year":"2006","journal-title":"Blood"},{"issue":"7","key":"10.1016\/j.cellsig.2023.110837_bb0270","doi-asserted-by":"crossref","first-page":"1040","DOI":"10.1182\/blood-2013-08-522698","article-title":"c-Myc inhibition prevents leukemia initiation in mice and impairs the growth of relapsed and induction failure pediatric T-ALL cells","volume":"123","author":"Roderick","year":"2014","journal-title":"Blood"},{"issue":"15","key":"10.1016\/j.cellsig.2023.110837_bb0275","doi-asserted-by":"crossref","first-page":"2096","DOI":"10.1101\/gad.1450406","article-title":"c-Myc is an important direct target of Notch1 in T-cell acute lymphoblastic leukemia\/lymphoma","volume":"20","author":"Weng","year":"2006","journal-title":"Genes Dev."},{"issue":"21","key":"10.1016\/j.cellsig.2023.110837_bb0280","doi-asserted-by":"crossref","first-page":"8022","DOI":"10.1128\/MCB.01091-06","article-title":"Notch1 contributes to mouse T-cell leukemia by directly inducing the expression of c-myc","volume":"26","author":"Sharma","year":"2006","journal-title":"Mol. Cell. Biol."},{"issue":"9","key":"10.1016\/j.cellsig.2023.110837_bb0285","doi-asserted-by":"crossref","first-page":"1685","DOI":"10.1007\/s00432-018-2696-3","article-title":"Disruption of MEK\/ERK\/c-Myc signaling radiosensitizes prostate cancer cells in vitro and in vivo","volume":"144","author":"Ciccarelli","year":"2018","journal-title":"J. Cancer Res. Clin. Oncol."},{"issue":"6336","key":"10.1016\/j.cellsig.2023.110837_bb0290","doi-asserted-by":"crossref","DOI":"10.1126\/science.aal3755","article-title":"Anticancer sulfonamides target splicing by inducing RBM39 degradation via recruitment to DCAF15","volume":"356","author":"Han","year":"2017","journal-title":"Science"},{"issue":"1","key":"10.1016\/j.cellsig.2023.110837_bb0295","doi-asserted-by":"crossref","DOI":"10.1101\/mcs.a000539","article-title":"Complete hematologic response of early T-cell progenitor acute lymphoblastic leukemia to the gamma-secretase inhibitor BMS-906024: genetic and epigenetic findings in an outlier case","volume":"1","author":"Knoechel","year":"2015","journal-title":"Cold Spring Harb. Mol. Case Stud."},{"issue":"4","key":"10.1016\/j.cellsig.2023.110837_bb0300","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1038\/ng.2913","article-title":"An epigenetic mechanism of resistance to targeted therapy in T cell acute lymphoblastic leukemia","volume":"46","author":"Knoechel","year":"2014","journal-title":"Nat. Genet."}],"container-title":["Cellular Signalling"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0898656823002516?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0898656823002516?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,14]],"date-time":"2026-05-14T12:46:18Z","timestamp":1778762778000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0898656823002516"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,10]]},"references-count":60,"alternative-id":["S0898656823002516"],"URL":"https:\/\/doi.org\/10.1016\/j.cellsig.2023.110837","relation":{},"ISSN":["0898-6568"],"issn-type":[{"value":"0898-6568","type":"print"}],"subject":[],"published":{"date-parts":[[2023,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Anlotinib exerts an anti-T-cell acute lymphoblastic leukemia effect in vitro and in vivo","name":"articletitle","label":"Article Title"},{"value":"Cellular Signalling","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cellsig.2023.110837","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"110837"}}